Spinal Cord Injury
📧 Sign up to get email alerts when something new happens for Spinal Cord Injury.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Patients With Spinal Cord Injury, Polytrauma and Burn Injury [Phase 2]
Phase 2 trial evaluating conditioning and open-label placebo to reduce opioid dose in patients with spinal cord injury, polytrauma, and burn…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: TNFα Monoclonal Antibody for Acute Spinal Cord Injury [Phase 1, Phase 2]
An early-stage clinical trial update for a TNFα monoclonal antibody targeting acute spinal cord injury, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Epi Stim to Facilitate Standing and Stepping [NA]
Clinical trial update for Epi Stim aiming to facilitate standing and stepping in spinal cord injury; study completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2022-04-14Clinical Trial Update: IONSYS Feasibility Study [Phase 4]
Feasibility study for IONSYS in spinal injury was withdrawn in Phase 4.
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Recovery of Cardiovascular Function With Epidural Stimulation After Human Spinal Cord Injury [NA]
A completed clinical trial studying recovery of cardiovascular function after spinal cord injury using epidural stimulation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Hybrid-FES Exercise to Prevent Cardiovascular Declines in Acute SCI [NA]
A completed clinical trial evaluating Hybrid-FES exercise to prevent cardiovascular decline in individuals with spinal cord injury; results …
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: ProACTIVE SCI Physical Activity Intervention [NA]
The ProACTIVE SCI physical activity intervention trial has completed, and results were posted on 2022-03-09. The study was sponsored by the …
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Combined Robotic Training and tDCS in Chronic SCI [Phase 3]
Phase 3 trial update for combined robotic training and transcranial direct current stimulation (tDCS) in chronic spinal cord injury.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Exoskeleton and Spinal Cord Injury [Phase 2]
A Phase 2 clinical trial update for an exoskeleton in spinal cord injury has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Clinical Setting (SC140121 Study 1 and 2) [NA]
A completed clinical trial assessing mobility and therapeutic benefits of exoskeleton use in spinal cord injury patients, with results poste…
-
FDA approval · 2022-02-04FDA Approved: BACLOFEN — Original Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved an Original Application for baclofen by Wilshire Pharmaceuticals, authorizing its use for treating spasticity.
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Enhancing Quality of Life Through Exercise: A Tele-Rehabilitation Approach [NA]
A completed clinical trial investigating tele-rehabilitation exercise to improve quality of life in individuals with spinal cord injury; res…
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Spinal Cord Stimulation to Augment Activity Based Therapy [NA]
Clinical trial update on using spinal cord stimulation to augment activity-based therapy for individuals with spinal cord injury; study comp…
-
FDA approval · 2022-01-25FDA Approved: BACLOFEN — Original Application (Major Pharmaceuticals)
FDA approved a generic baclofen under an Original Application from Major Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Targin® for Chronic Pain Management in Patients With Spinal Cord Injury [Phase 4]
Phase 4 clinical trial update for Targin in chronic pain management following spinal cord injury has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Autologous Bulbar Olfactory Ensheathing Cells and Nerve Grafts for Treatment of Patients With Spinal Cord Transection [Phase 1, Phase 2]
Clinical trial update for autologous bulbar olfactory ensheathing cells and nerve grafts in spinal cord injury (Phase 1/Phase 2).
-
FDA approval · 2021-11-22FDA Approved: LYVISPAH — Original Application (Amneal Pharmaceuticals LLC)
FDA approved LYVISPAH (baclofen) from Amneal Pharmaceuticals LLC as an Original Application. It is indicated for the management of spasticit…
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: Evaluation of Initiation Time on the Efficacy of Gabapentin in Treating Neuropathic Pain in SCI [Phase 4]
Phase 4 trial evaluating how initiation time affects gabapentin efficacy for neuropathic pain in spinal cord injury was completed with resul…
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Restoring Walking With a Powered Exoskeleton After Spinal Cord Injury [NA]
A completed trial evaluating a powered exoskeleton to restore walking in spinal cord injury patients; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Enhancing Corticospinal Activation for Improved Walking Function [NA]
A completed clinical trial investigated methods to enhance corticospinal activation to improve walking function in spinal cord injury patien…
-
FDA approval · 2021-09-22FDA Approved: BACLOFEN — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for baclofen from Chartwell RX, LLC, under ANDA077241, indicating regulatory approval of this supple…
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Utility of an Animated Bowel Biofeedback Training Routine to Improve Bowel Function in Individuals With SCI [NA]
A completed clinical trial evaluating an animated bowel biofeedback training routine to improve bowel function in individuals with spinal co…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: High Definition Neuromuscular Stimulation in Tetraplegia [NA]
Clinical trial update on high definition neuromuscular stimulation in tetraplegia due to spinal cord injury at C4-C6; trial completed with r…
-
FDA approval · 2021-07-13FDA Approved: BACLOFEN — Original Application (Medcore LLC)
FDA approves Medcore LLC's original ANDA for generic baclofen (oral) for the treatment of spasticity associated with multiple sclerosis and …
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Reanimation in Tetraplegia [NA]
Clinical trial update for reanimation in tetraplegia (spinal cord injury), status completed with results posted.